PharmaNutra Overview

  • Founded
  • 2003
  • Status
  • Public
  • Employees
  • 56
  • Stock Symbol
  • PHN
Stock Symbol
  • Share Price
  • $54.56
  • (As of Friday Closing)

PharmaNutra General Information


PharmaNutra SpA is a pharmaceutical company. It is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. Its products include SiderAL Folic, UltraMag, Cetilar, Gestalys DHA, Bonecal, Nasalt, Novomega, SiderAL, CardioSiderAL, DiKappa2, SiderAL Forte, and others. The company operates in Europe, Asia, the United States, and Africa.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Medical Supplies
Other Industries
Other Devices and Supplies
Stock Exchange
Primary Office
  • Via Delle Lenze, 216/b
  • 56122 Pisa
  • Italy
+39 050 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaNutra Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$54.56 $54.34 $25.47 - $57.28 $528M 9.7M 10.3K $1.68

PharmaNutra Financials Summary

In Thousands,
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 402,037 431,382 242,904 157,960
Revenue 68,734 66,662 60,285 55,231
EBITDA 16,320 16,158 14,555 14,735
Net Income 16,219 16,041 9,464 10,098
Total Assets 65,594 63,600 54,736 47,438
Total Debt 1,825 2,041 7,164 6,111
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PharmaNutra Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PharmaNutra‘s full profile, request access.

Request a free trial

PharmaNutra Executive Team (3)

Name Title Board Seat Contact Info
Roberto Lacorte Co-Founder, Chief Executive Officer, Vice President & Executive Director
Andrea Lacorte Co-Founder, President & Executive Director
Carlo Volpi Chief Operating Officer & Managing Director
To view PharmaNutra’s complete executive team members history, request access »

PharmaNutra Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PharmaNutra Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PharmaNutra‘s full profile, request access.

Request a free trial